Clinical Study
Clinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status
Table 3
Clinical characteristics of responder and nonresponder group after eradication therapy.
| | Variables | Responder () | Nonresponder () | value |
| | Mean age (SD) | 58.7 (10.8) | 59.2 (11.4) | 0.259 | | Gender (%) | | | 0.252 | | Male | 12 (32) | 5 (56) | | | Female | 26 (68) | 4 (44) | | | H. pylori status (%) | | | 0.075 | | Positive | 35 (92) | 6 (67) | | | Negative | 3 (8) | 3 (33) | | | Site of lesion (%) | | | 0.270 | | Proximal | 23 (61) | 3 (33) | | | Distal | 11 (29) | 5 (56) | | | Both | 4 (10) | 1 (11) | | | Number of lesions (%) | | | 0.023 | | Single | 22 (58) | 1 (11) | | | Multiple | 16 (42) | 8 (89) | | | Endoscopic finding (%) | | | 0.302 | | Superficial type | 32 (84) | 8 (89) | | | Advanced cancer-like type | 6 (16) | 1 (11) | | | Clinical stage (%) | | | 0.650 | | I | 36 (95) | 9 (100) | | | II or more | 2 (5) | 0 (0) | |
|
|
Cardia, fundus, high body, or midbody. Low body, angle, or antrum.
SD: standard deviation; H. pylori: Helicobacter pylori.
|
